Clinical Manifestation and Psychopharmacotherpy of Pediatric Bipolar Disorder

Causes of pediatric heart disease in Rasht and its relationship with clinical ‎manifestation and demographic characteristic

Introduction: Heart disease is the fifth cause of death in infants and children and ‎‏%90‏‎ of ‎these causes are related to congenital heart diseases.Nearly‏%20‏‎ of these children experience ‎heart failure and surgery, but life expectancy for these children is increased by palliative and ‎corrective surgeries. Demographic characteristics and clinical sym...

Sibutramine-induced mania as the first manifestation of bipolar disorder

BACKGROUND Sibutramine, used in obesity treatment, has been associated with many neuropsychiatric side effects including hypomanic and manic episodes. Hypomanic/manic episodes related to sibutramine treatment were earlier reported in patients who had previous history of bipolar disorder, after sibutramine overdose, after over-the-counter product illegally containing very high dose of sibutramin...

Manifestation of Bipolar Affective Disorder: Post Brain Injury

Case report: bipolar disorder as the first manifestation of CADASIL

BACKGROUND Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited cerebrovascular disease, clinically characterized by variable manifestations of migraine, recurrent transient ischemic attack or lacunar strokes, cognitive decline, and mood disturbances. However, manic episodes have rarely been documented as an initial symptom of CADA...

Pharmacotherapeutic strategies for pediatric bipolar disorder.

There has been a recent increase in recognition and diagnosis of pediatric bipolar disorder (PBD), along with an increase in prescriptions for psychotropic medications for treating children suffering from this chronic, potentially disabling disorder. Lithium remains the only FDA-approved mood stabilizer for use in children > 12 years of age and along with valproic acid and carbamazepine, forms ...